John Harling
Company: GlaxoSmithKline
Job title: Senior Scientific Director of Medicinal Chemistry
Bio:
I conducted both my B.Sc and Ph.D at Imperial followed by two years as a Postdoctoral Researcher at the University of Texas at Austin. Joined GlaxoSmithKline (then SmithKlineBeecham) as a Medicinal Chemist in 1991. During my >25 years at GSK I have worked in programs spanning Neurosciences, Cardiovascular and Respiratory therapeutic areas. In 2007 I was appointed as a Medicinal Chemistry Department Head in the Respiratory therapeutic area. In 2012 I became involved in the initiation of an exploratory effort to assess the potential of a new protein degradation technology through collaboration with Professor Craig Crews at Yale. My current position is Senior Scientific Director within Medicinal Chemistry at GSK where I have a remit to develop protein degradation capability at GSK.
Seminars:
Discussion/Q&A 10:15 am
day: Day Two
Discussion/Q&A 12:10 pm
day: Day One
Discussion/Q&A 5:10 pm
day: Day One
Chair’s Opening Remarks 8:55 am
day: Day Two
Chair’s Closing Remarks & End of Day One 5:30 pm
day: Day One